Unit 9: Neurological/Psych Flashcards
First line treatment for tension headaches
Acetaminophen and aspirin
Second line treatment for tension headaches
NSAIDs and excedrin
Prophylactic treatment for tension headaches
Antidepressants–amitriptyline
First line treatment for mild to moderate migraine
NSAIDs and aspirin
First line treatment for moderate to severe migraine
Triptans
Triptans
5-HT1 receptor agonists
Cause cerebral vasoconstriction and can treat both pain and nausea of migraine
Opioids for migraine
Used as rescue medication for severe migraines that do not respond to other medications
Used sparingly
Butorphanol, tramadol, acetaminophen + caffeine
Steroids for migraine
Can be used as rescue medication until patient is free for 24 hours
Prophylactic drugs for migraine
Anticonvulsants, beta blockers, triptans, ACEI, ARB, ca channel blocker, TCA, SSRI/SNRI, antihistamines, botox
First line therapy for partial seizures
Carbamazepine, phenytoin, fosphenytoin, valproic acid, lamotrigine, lacosamide, topiramate, oxcarbazepine
First line therapy for generalized tonic clonic seizures
Carbamazepine, lacosamide, phenytoin, valproic acid, fosphenytoin
First line therapy for absence seizures
Ethosuximide, valproic acid, lamotrigine
First line therapy for atypical absence, myoclonic, and atonic seizures
Valproic acid
Hydriantoins
Phenytoin + fosphenytoin
Most commonly used anti seizure meds
Increases efflux and decreases influx of Na
SE of phenytoin
gingival hyperplasia, hirsutism, rash, peripheral neuropathy
Benzodiazepines used for seizures
Clobazam, clonazepam, lorazepam (SE), diazepam
First line therapy for status epilepticus
IV benzodiazepine
4 common strategies for modifying drug therapy for major depressive disorder
increase dose, switch to different drug in same class, switch to different class, augment current drug, combine meds
Examples of SSRIs
Fluoxetine, citalopram, fluvoxamine, paroxetine, sertraline, escitalopram
Common SE of SSRI
Sexual dysfunction, potential to induce anxiety/insomnia–decreases REM sleep
Abrupt withdrawal of SSRI
flu like symptoms, insomnia, GI effects, anxiety
SNRIs
venlafaxine, desvenlafaxine, duloxetine, levomilnacipran
Indicated for more severe or resistant depression
SE of SNRI
More anticholinergic effects
TCA’s
-triptyline or -amine
Same efficacy as SSRI but worse SE- Anticholinergic effects, weight gain, life threatening cardiac conduction abnormalities, hypotension, sedation
Atypical antidepressants
Amoxapine, buproprion, maprotiline, mirtazapine, nefazodone, trazodone
MAO Inhibitors
Decrease degradation of NE, 5-HT, and dopamine
Increased SE and potential for hypertensive crises
Limited use
Phenelzine
Major neurotransmitters studied in anxiety pharmacology
NE, serotonin, GABA
Ideal anxiolytic therapy
Should promote calmness without resulting in daytime sedation and drowsiness and without producing physical or psychological dependence
What drugs are indicated in anxiety
Antidepressants, benzodiazepines, azapirones, novel anti-anxiety meds, and atypical antipsychotics
First line therapy for chronic management of anxiety disorders
Antidepressants
SSRI: citalopram, escitalopram, fluvoxamine, paroxetine, sertraline
SNRI: venlafaxine, duloxetine
TCAs: Imipramine
What drugs are indicated for short term management of anxiety
Benzodiazepines
2-4 weeks
Also used for acute exacerbations
Examples of benzodiazepines used for anxiety
Alprazolam: Xanax Clonazepam Diazepam Lorazepam: Ativan Oxazepam
What drug is used in benzodiazepine OD
Flumazenil
Azapirones
Buspirone
Partial agonist at 5-HT1a receptor
Used as adjunct therapy for anxiety
MAOI in anxiety
Effective for panic attacks but not GAD
First line treatment for GAD
SSRI or SNRI
Must give benzo initially until anti depressant begins to work
Second line treatment for GAD
Imipramine or buspirone
First line treatment for panic disorder
SSRI or venlafaxine
First line treatment for social anxiety
SSRI and venlafaxine
Drugs used to manage insomnia
Benzodiazepines, orexin receptor agonists, melatonin receptor agonist, first generation H1 blocker
Benzodiazepines for insomnia
Bind to GABA in ascending RAS: blocks thalamus, hypothalamus, and limbic arousal
Flurazepam
Long acting and rapid onset–used for sleep initiation
Temazepam and Lorazepam
Intermediate acting
Used for sleep maintenance
Benzodiazepine Receptor Agonists
Selective for alpha 1 of GABA A receptor–induces sleepiness but not anxiolysis or muscle relaxation
Long term use not recommended
Can increase parasomnias
Examples of benzodiazepine receptor agonists
Eszoplicone, zolpidem (ambien), and zaleplon
Orexin receptor antagonists
Suvorexant
Blockage of orexin neuropeptides–causes severe sleepiness
Achieves sleep initiation and maintenance
Melatonin receptor agonists
Ramelteon
High affinity for MT1 and MT2 receptors
Shorten latency to sleep onset
Antihistamines for insomnia
Diphenhydramine: Benadryl
Competitively inhibits H1 receptor causing sedative and anticholinergic effects
Antidepressants for insomnia
Mirtazapine, Trazadone, Doxepin
Sedating antidepressants for use with co-morbid depression
First line therapy for short term insomnia
Benzodiazepines, benzo receptor agonist, ramelteon
Meds for restless leg syndrome
Dopaminergic agonists, opioids, benzos, anticonvulsants
Dopaminergic agonists for restless leg syndrome
Ropinirole + pramipexole, low dose cardidopa-levodopa
Narcoleptic triad
Excessive daytime sleepiness, cataplexy, sleep related hallucinations, sleep paralysis
Diagnosis of narcolepsy
Presence of excessive sleepiness, levels of hypocretin in CSF, and multilatency sleep test
Psychostimulants for narcolepsy
Modafenil + Armodafinil
Increase release of NE in subregions of hippocampus, centro lateral nucleus of thalamus and central nucleus of amygdala
Amphetamines for narcolepsy
Methylpenidate
Stimulates CNS activity and blocks reuptake of NE
Sodium oxybate
Approved to treat excessive daytime sleepiness and cataplexy
ADHD pathophys
Decreased volume and functionality in prefrontal cortex/caudate and cerebellum–deficits in cognition, attention, motor planning, and processing speed
Problems with dopamine and NE
First line treatment for ADHD
Stimulants
Second line treatment for ADHD
Non stimulants
Third line treatment for ADHD
Buproprion
Stimulant medications
methylphenidate + amphetamines
Inhibit re-uptake of dopamine and NE
amphetamines also directly cause release of dopamine and NE from presynaptic cell
SE of stimulant meds for ADHD
Sleep disturbances, decreased appetite, weight loss, agitation, nervousness
Nonstimulants for ADHD
Used if patient has CI to stimulant
Atomexetin, guanfacine, clonidine, buproprion
Atomexitine
Nonstimulant
Selectively inhibits reuptake of NE by inhibiting presynpatic NE transporter
alpha 2 agonists
Guanfacine + Clondidine
Decreases NE release
Decreases hyperactivity, impulsivity, and distractibility
Pathophys of Alzheimer Disease
ACh levels are decreased and excessive stimulation of glutamate
First line tx for AD
Cholinesterase inhibitors Or Memantine (more severe forms) or combo
Cholinesterase inhibitors
Tx of cognitive symptoms
Donepezil, rivastigmine, galantamine
SE are cholinergic: DUMBBELSS
Memantine
NMDA antagonist
Decreases glutamate
tx of cognitive symptoms
inhibits neuronal degeneration
Antipsychotics for noncognitive symptoms of AD
Atypical antipsychotics preferred due to decreased EPS symptoms
Benzos for AD
Tx of anxiety of episodic agitation
Lorazepam or Alprazolam
Long term use may worsen symptoms of AD
Antidepressants for AD
Sertraline or Citalopram first line
Drug induced parkinsonism may be due to
Typical antipsychotics or neuroleptic drugs
-Chlorpromazine, promazine, haloperidol, perphenazine, fluphenazine, pimozide, metoclopramide, valproic acid, methyldopa
Symptoms of parkinson disease are due to
Decrease in dopamine–leads to breakdown of communication to motor regulators within the brain
Hallmark signs of parkinson disease
Bradykinesia, resting tremor, cogwheel rigidity, difficulty maintaining balance
Mild potency drugs for PD
Anticholinergics, amantadine, MAO-B inhibitors
Anticholinergics for PD
Useful for treating drooling and tremor
Trihexyphenidyl + Benztropine
SE: anticholinergic
Amantadine
May inhibit NMDA receptor
MAO-B inhibitors
Modest improvement of motor symptoms
Selegiline + Rasagiline
Inhibits MAO-B metabolism of dopamine
Moderate potency drugs for PD
Dopamine agonists
Dopamine agonists
Less effective than levodopa but less dyskinesia seen
Pramipexole, ropinirole, rotigutine
High potency drugs for PD
Levodopa and catechol-o-methyltransferase inhibitors
Levodopa
Most effective tx for symptomatic relief of PD
Fastest onset of action
Can cross bbb and then converted to dopamine
Administered with carbidopa to limit peripheral breakdown
Catechol-o-methyltransferase inhibitors
Entacapone + Tolcapone
Used in combo with levodopa to decrease wearing off effect
Can increase risk of dyskinesia
Decreases peripheral breakdown of levodopa